-
Association of eGFR Decline and Cardiovascular Outcomes in Chronic Kidney Disease Patients: Feasibility of Frequency Matching Replicating Event-Driven Clinical Trials With Real-World Data Long-Term
Sep 9, 2025, 16:22 PM -
Expanding Health Coverage to Reduce Direct and Indirect Costs: A Territorial Equity Approach in Colombia
Sep 9, 2025, 16:22 PM -
Applicability of the STEDI Value Framework to Vaccines in Health Technology Assessment: Opportunities and Considerations
Sep 9, 2025, 16:22 PM -
Patients With Lupus Across Germany: An AI/ML Driven Method to Maximize Patient Selection From Longitudinal Prescription Data (IQVIA LRx)
Sep 9, 2025, 16:22 PM -
Measuring Quality of Life in Huntington’s Disease Using a Proxy Approach: Validation of the HD-mQoL-prx Measure
Sep 9, 2025, 16:22 PM -
Effectiveness of Psychosocial Interventions for Adults With Substance Use Disorder and Co-Occurring Mental Health Disorder: An Umbrella Review
Sep 9, 2025, 16:22 PM -
Estimated Long-Term Healthcare Cost Savings From EVP Use in the UK
Sep 9, 2025, 16:22 PM -
Advocating From the Margins: How Patient Input Aligns With Broader Evidence Tolerance in HTA Within Oncology
Sep 9, 2025, 16:22 PM -
Considerations for Modeling Caregiver Spillover Within Economic Evaluations for Neurological Disorders: Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy (DMD), and Multiple Sclerosis (MS)
Sep 9, 2025, 16:22 PM -
The Economic Value of Diagnostic Strategies in Hepatitis D: A Methodological Review of Cost-Effectiveness Models
Sep 9, 2025, 16:22 PM -
Health Economic Modeling Approaches for Assessing the Value of a Clostridioides Difficile Vaccination Program: A Literature Review
Sep 9, 2025, 16:22 PM -
Negative Symptoms in Schizophrenia: An Observational Study of Patient Characteristics Cost and Healthcare Resource Utilization From a US Healthcare Database
Sep 9, 2025, 16:22 PM -
The Broader Economics of Chronic Spontaneous Urticaria (CSU) in Japan: Assessing Societal and Fiscal Benefits of Novel Therapies
Sep 9, 2025, 16:22 PM -
Real-World Clinical and Economic Outcomes of Time in Range in Association With Diabetic Retinopathy Among Patients With Type I Diabetes
Sep 9, 2025, 16:22 PM -
Electronic Health Records in China: Challenges and Opportunities for Real-World Evidence Generation
Sep 9, 2025, 16:22 PM -
Economic Impact of Faricimab in Neovascular Age-Related Macular Degeneration Management in France
Sep 9, 2025, 16:22 PM -
Work Productivity Loss Among Caregivers of Pediatric Patients With COVID-19 OR Influenza/Influenza-Like Illness: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Model of Ranolazine for Treating Chronic Stable Angina Patients From Kingdom of Saudi Arabia Perspective
Sep 9, 2025, 16:22 PM -
Payer and HTA Evaluation Criteria and Considerations for Coverage and Reimbursement of Patient Self-Monitoring Technology
Sep 9, 2025, 16:22 PM -
Health Service Utilization and Its Determinants Among National Health Insurance Participants in Indonesia: A Community-Based Survey
Sep 9, 2025, 16:22 PM